Skip to main content

David Rimm, MD, PhD

David Rimm, MD, PhD
Conference Coverage
01/05/2024
David Rimm, MD, PhD, discussed study results which identified quantitative multiplex immunofluorescence assay as an optimal way to detect TROP2 and HER2 expression in breast cancer.
David Rimm, MD, PhD, discussed study results which identified quantitative multiplex immunofluorescence assay as an optimal way to detect TROP2 and HER2 expression in breast cancer.
David Rimm, MD, PhD, discussed...
01/05/2024
Oncology